The role of microglial activation in disease progression

Area of Science:

• Neuroimmunology
• Cellular Biology
• Neurodegeneration

Background:

• Microglia, myeloid cells in the central nervous system, are central to neuroinflammation in multiple sclerosis (MS).
• These cells contribute to neurodegeneration through pro-inflammatory mediators and are implicated in cortical lesions and synaptic dysfunction in experimental autoimmune encephalomyelitis (EAE).
• Microglia also possess neuroprotective roles, including inflammation downregulation and tissue repair stimulation.

Purpose of the Study:

• To explore the dual role of microglia in multiple sclerosis (MS) pathogenesis and repair.
• To understand how microglial function changes with aging and impacts neurodegeneration.
• To inform therapeutic strategies targeting microglial activation in MS.

Main Methods:

• Review of existing literature on microglia in MS and aging.
• Analysis of microglial pathways involved in neuroinflammation and neuroprotection.
• Consideration of age-related changes in microglial function.

Main Results:

• Microglia exhibit both detrimental (neurotoxic pathways) and beneficial (neuroprotection, repair) functions in MS.
• Aging impairs microglial repair capabilities, increasing neuronal vulnerability.
• Microglial activation patterns differ between acute and chronic MS stages.

Conclusions:

• Microglia are critical players in MS, with a complex role in both disease progression and potential recovery.
• Therapeutic modulation of microglia requires a nuanced approach to harness protective functions while mitigating damaging ones.
• Age-related decline in microglial function poses challenges for CNS repair in older MS patients.